Drawing for OXFORD BIOLABS

USPTO serial 79152740

OXFORD BIOLABS

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
Examiner
BEN, LINDSEY HEATHER
Law office
TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OXFORD BIOLABS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

M. Scott Alprin

M. Scott Alprin Alprin Law Offices, P.C.5 Pinehurst Circle, N.W.Washington, DC 20015UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Cosmetics; non-medicated toiletries; makeup; concealers, including hair loss concealers; non-medicated soaps; perfumery; aromatherapy preparations, namely, essential oils for use in aromatherapy, non-medicated skin creams with essential oils for use in aromatherapy, essential oils and essential oils blends; anti-perspirants and deodorants, namely, body deodorants, deodorants for body care, deodorants for personal use; talcum powder; hair removal preparations, namely, hair removal cream, hair removal lotions, wax for removing body hair; hair care preparations, including but not limited to shampoos, conditioners, waxes, styling gels and hair dyes and colorants; skin care cosmetics including but not limited to cremes, emulsions, oils, gels; colouring lotions for the hair; hair lotions; hair styling lotions; hair sprays; hair thickeners, namely, hair thickening shampoos, conditioners, creams, lotions and sprays; nail care preparations; potpourri; bath salts, bubble bath; dentifrices; cosmetics for animals; shampoos for animals; deodorant preparations for use on animalsSECTION 70 - CANCELLED
005Pharmaceutical preparations for hair loss, hair disorders, anti-ageing, relief of pain, treatment of gastrointestinal diseases, treatment of infectious diseases eye health, heart, bone-density, sleep aid/insomnia, joint health, immune system, weight loss, anxiety, varicose veins, back pain, intestinal parasite, dizziness, impotency, female enhancement, healthy bowel, lactose intolerance, nerves, allergies, sperm motility, anti-depression, kidney stones, sun tan, cellulite, warts, genital warts, acne, viral infections, pregnancy, menopause; pharmaceutical preparations acting on the central nervous system; antiallergic medicines; anti-diabetic pharmaceuticals; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating allergies, allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations for the treatment of eye diseases and conditions; medicinal hair growth preparations; medicated cosmetic preparations for the hair and scalp; dietetic substances for medical use, namely, food supplements, food supplement pills and pastilles, food supplement beverages, nutritionally fortified beverages; diabetic foodstuffs, namely, food supplements, food supplement pills and pastilles, food supplement beverages, nutritionally fortified beverages; herbal preparations for medical purposes; herbal supplements and herbal extracts for medical purposes; herbal beverages for medical purposes; minerals and mineral preparations, namely, mineral supplements, mineral preparations for medical purposes; mineral food supplements; food supplements; dietetic foods for use in clinical nutrition, namely, food supplements, food supplement pills and pastilles food supplement beverages, nutritionally fortified beverages; food and beverage products for medically restricted diets, namely, food supplements, food supplement pills and pastilles, food supplement beverages, nutritionally fortified beverages; medicinal hair growth preparations; amino acids for medical purposes; amino acids for veterinary purposes; supplements for foodstuffs for animals; supplements for foodstuffs for human consumption; animal care products for veterinary use, namely, animal feed supplements, protein supplements for animals, vitamin and dietary food supplements for animals; medicated animal washesSECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 1, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 1, 2024DETHDEATH OF INTERNATIONAL REGISTRATION
Jul 26, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED
Nov 11, 2016FINTFINAL DECISION TRANSACTION PROCESSED BY IB
Oct 24, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB
Oct 22, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 18, 2016OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 2, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 2, 2016OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 22, 2015MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 22, 2015ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 26, 2015GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Mar 26, 2015GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 26, 2015CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 26, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 31, 2014RFNTREFUSAL PROCESSED BY IB
Oct 15, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 15, 2014RFRRREFUSAL PROCESSED BY MPU
Oct 14, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 13, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 10, 2014MAFRAPPLICATION FILING RECEIPT MAILED
Oct 6, 2014DOCKASSIGNED TO EXAMINER
Oct 6, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 2, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance